Biofrontera Inc <BFRI.OQ> expected to post a loss of 2 cents a share - Earnings Preview

• Biofrontera Inc BFRI.OQ BFRI.O is expected to show a rise in quarterly revenue when it reports results on March 21 for the period ending December 31 2024

• The Woburn Massachusetts-based company is expected to report a 37.1% increase in revenue to $14.531 million from $10.6 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Biofrontera Inc is for a loss of 2 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Biofrontera Inc is $11.50​, above​ its last closing price of $0.88. ​​​

This summary was machine generated March 11 at 20:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)